UK prescriptions for cannabis-based medicines double in a year, CQC report says
The pharmaceutical journal writes According to the Care Quality Commission’s report, the number of cannabis-based products for medicinal use prescribed on the NHS was so small that reporting details “could potentially breach patient confidentiality”. Prescriptions for unlicensed cannabis-based products for medicinal use (CBPMs) more than doubled in England between 2021/2022 and 2022/2023, Care Quality Commission […]
